Ultradeformable liposomes containing amphotericin B (AmB-UDL) were prepared to enhance AmB topical delivery for treatment of cutaneous fungal infections and leishmaniasis.
Fungal strains (albicans and non-albicans Candida ATCC strains and clinical isolates of C. albicans) were more sensitive than mammal cells to AmB-UDL.
AmB-UDL showed 100 and 75% anti-promastigote and anti-amastigote activity on L. braziliensis.
Total accumulation of AmB in skin was 40 times higher when applied as AmB-UDL than as AmBisome.